Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.
Hope S RugoSara M TolaneyDelphine LoiratKevin PunieAditya BardiaSara Alsterlind HurvitzJoyce O'ShaughnessyJavier CortesVéronique DiérasLisa Anne CareyLuca GianniMartine J PiccartSibylle LoiblDavid M GoldenbergQuan HongMartin OlivoLoretta M ItriKevin KalinskyPublished in: NPJ breast cancer (2024)